Lung cancer is one of the most common cancer in the world. It’s a cancer that begins in the lungs and most often occurs in the people who smoke.
Lung cancer is one of the most common cancer in the world. It’s a cancer that begins in the lungs and most often occurs in the people who smoke. Excessive smoking, this may be in the form of active or passive, tobacco intake, high level of pollution, radiations, and exposure increases the risk of lung cancer. Symptoms of lung cancer are cough that doesn’t go away and becomes worst day by day, wheezing, shortness of breath, constant chest pain, loss of appetite or weight loss, swelling of neck and face, and bloody mucus. This disease is diagnosed by using physical exam, imaging and lab test.
Some of the factors that support growth of the global lung cancer therapeutics market are rising number of smokers, launch of innovative drugs, new radiation therapies. In addition to this, constant exposure of asbestos, rising geriatric population and rise in prevalence of unhealthy life styles are also few factors that driving the global lung cancer therapeutic market. Availability of generic drugs, poor cancer diagnostic facilities in emerging countries, high cost of drugs and adverse effect of radiation and chemotherapy are factors likely to restrain the global lung cancer therapeutics market during the forecast period. However, government funding in the field of research and development of new drugs and increasing pollution due to rapid industrialization are some of the reasons driving growth of this market.
The global lung cancer therapeutics market has been segmented on the basis of cell type, and region.
North America and Europe dominates the global lung cancer therapeutic market. Asia Pacific is projected to foresee the highest growth rate in the global lung cancer therapeutics market, due to rising prevalence of this disease and increasing health awareness. Europe accounts the second largest market after North America.
To Obtain All-Inclusive Information On Forecast Analysis, Request A FREE Pdf Sample Report Here: https://marketresearch.biz/report/lung-cancer-therapeutic-market/request-sample/
Key players profiled in the global lung cancer therapeutic market report include AstraZeneca Plc, GlaxoSmithKline Plc, F. Hoffmann-La Roche Ltd, Eli Lilly and company, Boehringerlngelheim GmbH, Pfizer Inc., Sanofi-Aventis, Agennix AG, Celegan, AbbVie.